BPC-157 | TB-500 (Capsules)
Tissue Repair Blend (Oral)
Blend Components:
BPC-157
CAS: 137525-51-0
Formula: C62H98N16O22
M.W.: 1419.5347 g/mol
TB-500
CAS: 77591-33-4
Formula: C212H350N56O78S
M.W.: 4963.4421 g/mol
Purity: 99%+ HPLC Verified
Ref No.: BTS-0500TA
For Research Use Only (RUO)
Not for human or veterinary use.
BPC-157 | TB-500 (Capsules)
Category
Regenerative Research
CAS Number
N/A
Form Factor
Capsules
Blend Components
BPC-157
500 mg
CAS: 137525-51-0
TB-500
500 mcg (60 ct)
CAS: 77591-33-4
BPC-157
CAS
137525-51-0
Formula
C62H98N16O22
Molar Mass
1419.5347 g/mol
TB-500
CAS
77591-33-4
Formula
C212H350N56O78S
Molar Mass
4963.4421 g/mol
In stock, ready to ship
Ships same day before 12pm PST
Products are shipped in capsule form.
This encapsulated research formulation combines BPC-157 and TB-500 for experimental characterization of gastrointestinal stability, mucosal transport, and systemic biodistribution. Research examines BPC-157-associated cytoprotective signaling alongside TB-500-associated cellular migration, cytoskeletal regulation, and inflammatory-response pathways, including potential effects of co-formulation on peptide integrity and bioavailability. For laboratory research use only.
Description
This encapsulated research formulation combines BPC-157 and TB-500 for experimental characterization of gastrointestinal stability, mucosal transport, and systemic biodistribution. Research examines BPC-157-associated cytoprotective signaling alongside TB-500-associated cellular migration, cytoskeletal regulation, and inflammatory-response pathways, including potential effects of co-formulation on peptide integrity and bioavailability. For laboratory research use only.Chemical Information
Purity
99%+ HPLC Verified
Form Factor
Capsules
Synonyms
Blend Components
BPC-157
500 mg
CAS: 137525-51-0
TB-500
500 mcg (60 ct)
CAS: 77591-33-4
BPC-157
CAS
137525-51-0
Formula
C62H98N16O22
Molar Mass
1419.5347 g/mol
TB-500
CAS
77591-33-4
Formula
C212H350N56O78S
Molar Mass
4963.4421 g/mol
Research Applications
- Enteral Combination-Delivery Research: This dual-peptide formulation is investigated in experimental gastrointestinal models to characterize peptide stability, mucosal transport, and bioavailability. Studies examine whether BPC-157 influences TB-500 stability or transport during simulated gastrointestinal transit and whether co-formulation alters the behavior of either peptide.
- Gastroenterology Research: The BPC-157 and TB-500 combination is evaluated for its interactions with gastrointestinal mucosa and systemic tissue-remodeling pathways. Research endpoints include epithelial-barrier integrity, cytoprotective signaling, inflammatory-response markers, peptide biodistribution, and comparisons with parenteral delivery models.
- Pharmaceutical Sciences: The formulation is studied to optimize multi-peptide stability and gastrointestinal transport. Investigations assess encapsulation methods, individual absorption kinetics, peptide–peptide interactions, enteric-coating systems, excipient compatibility, and other delivery technologies designed to preserve peptide integrity and improve experimental bioavailability.
Storage Conditions
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
Safety & Compliance
- Wear nitrile gloves and safety goggles when handling research compounds.
- Work in a clean, controlled environment (laminar flow hood recommended).
- Dispose of sharps and used materials in approved biohazard containers.
- This product is for laboratory research use only (RUO) — not for human or veterinary use.
Quality Assurance Standards
Each production lot is subjected to rigorous analytical evaluation to meet pharmaceutical-grade specifications. Full testing results and procedural documentation are furnished through the accompanying Certificate of Analysis (COA) with every shipment.
Certificate of Analysis
Latest COA for BPC-157 | TB-500 (Capsules) — independently tested via HPLC and Mass Spectrometry.
Testing Methodology
Every batch undergoes a multi-stage analytical pipeline before release. Results are compiled into the Certificate of Analysis (COA) included with each order.
- • HPLC — High-Performance Liquid Chromatography confirms peptide purity ≥98%.
- • Mass Spectrometry — Validates molecular identity and correct sequence.
- • Endotoxin (LAL) — Limulus Amebocyte Lysate assay ensures endotoxin levels are within safe limits.
- • Sterility — Microbial contamination testing per USP standards.
Learn More About Peptides
Explore our research library covering purity, synthesis, storage, solubility, and more.
Research Database
Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
You May Also Like
-
$124.99
Semax (Spray)
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$99.99
NAD+ (Spray)
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$109.99
BPC-157 (Spray)
Regenerative ResearchThis product has multiple variants. The options may be chosen on the product page View Details -
$124.99
Selank (Spray)
GH / Neuro / Misc ResearchThis product has multiple variants. The options may be chosen on the product page View Details
Popular Product
Popular Product
Popular Product
Popular Product
Description
This encapsulated research formulation combines BPC-157 and TB-500 for experimental characterization of gastrointestinal stability, mucosal transport, and systemic biodistribution. Research examines BPC-157-associated cytoprotective signaling alongside TB-500-associated cellular migration, cytoskeletal regulation, and inflammatory-response pathways, including potential effects of co-formulation on peptide integrity and bioavailability. For laboratory research use only.Chemical Information
Purity
99%+ HPLC Verified
Form Factor
Capsules
Synonyms
Blend Components
BPC-157
500 mg
CAS: 137525-51-0
TB-500
500 mcg (60 ct)
CAS: 77591-33-4
BPC-157
CAS
137525-51-0
Formula
C62H98N16O22
Molar Mass
1419.5347 g/mol
TB-500
CAS
77591-33-4
Formula
C212H350N56O78S
Molar Mass
4963.4421 g/mol
Research Applications
- Enteral Combination-Delivery Research: This dual-peptide formulation is investigated in experimental gastrointestinal models to characterize peptide stability, mucosal transport, and bioavailability. Studies examine whether BPC-157 influences TB-500 stability or transport during simulated gastrointestinal transit and whether co-formulation alters the behavior of either peptide.
- Gastroenterology Research: The BPC-157 and TB-500 combination is evaluated for its interactions with gastrointestinal mucosa and systemic tissue-remodeling pathways. Research endpoints include epithelial-barrier integrity, cytoprotective signaling, inflammatory-response markers, peptide biodistribution, and comparisons with parenteral delivery models.
- Pharmaceutical Sciences: The formulation is studied to optimize multi-peptide stability and gastrointestinal transport. Investigations assess encapsulation methods, individual absorption kinetics, peptide–peptide interactions, enteric-coating systems, excipient compatibility, and other delivery technologies designed to preserve peptide integrity and improve experimental bioavailability.
Storage Conditions
Unreconstituted
Store at -20°C to 4°C (freezer or refrigerator). Stable for 24+ months.
Reconstituted
Refrigerate at 2–8°C. Use within 30 days for optimal stability.
Avoid
Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C.
Safety & Compliance
- Wear nitrile gloves and safety goggles when handling research compounds.
- Work in a clean, controlled environment (laminar flow hood recommended).
- Dispose of sharps and used materials in approved biohazard containers.
- This product is for laboratory research use only (RUO) — not for human or veterinary use.
Quality Assurance Standards
Each production lot is subjected to rigorous analytical evaluation to meet pharmaceutical-grade specifications. Full testing results and procedural documentation are furnished through the accompanying Certificate of Analysis (COA) with every shipment.
Certificate of Analysis
Latest COA for BPC-157 | TB-500 (Capsules) — independently tested via HPLC and Mass Spectrometry.
Testing Methodology
Every batch undergoes a multi-stage analytical pipeline before release. Results are compiled into the Certificate of Analysis (COA) included with each order.
- • HPLC — High-Performance Liquid Chromatography confirms peptide purity ≥98%.
- • Mass Spectrometry — Validates molecular identity and correct sequence.
- • Endotoxin (LAL) — Limulus Amebocyte Lysate assay ensures endotoxin levels are within safe limits.
- • Sterility — Microbial contamination testing per USP standards.
Learn More About Peptides
Explore our research library covering purity, synthesis, storage, solubility, and more.
Research Database
Browse peer-reviewed studies, clinical trials, and scientific sources behind our peptide resources.
